To gain a better understanding of how good/bad Thermalife,Tripeptofen and Pharmanet Ltd can be, I seems appropriate to discuss the competition and the market in which it competes.
Voltaren (Norvatis) appears as one major competitive product with over $1 Billion in worldwide sales. It has however received some negative press results from Danish scientific research :
http://www.3news.co.nz/Calls-for-Voltaren-ban-following-stroke-study/tabid/309/articleID/176050/Default.aspx
Endo pharmaceuticals reports a 54% increase in first qtr sales 2011 of Voltaren gel in the US. They paid Norvatis $85million upfront for the exclusive US distribution rights!
http://www.medicalnewstoday.com/releases/99586.php
The challenge is very serious and the prize could be absolutely huge...it all comes down to management's ability
to present the facts and performance of the products to the world in a LOUD, CLEAR,UNITED voice !!!
Mr John Palermo, if you read this, a nice multi-page power presentation to remind the world that the company means business and the competition should take note of the power of TRIPEPTOFEN as an alternative to diclofenac !
PS: Pls update the website URGENTLY and consider online sales, Thankyou !
thermalife vs voltaren ?
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $93.67M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.5¢ | $265.3K | 2.456M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11766 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 336976 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CAI (ASX) Chart |